A HIV infected patient was treated for stage IVB Hodgkin's lymphoma by ABVD (doxorubicine, bleomycine, vinblastine, dacarbazine) chemotherapy and lopinavir-ritonavir based antiretroviral therapy inducing profound life-threatening neutropenia. Vinblastine and lopinavir-ritonavir interaction was managed with lopinavir-ritonavir interruption around chemotherapy administration, with complete remission and immunovirological success after six cycles. This unrecorded strategy is discussed. © 2007 The Authors.
CITATION STYLE
Makinson, A., Martelli, N., Peyrière, H., Turriere, C., Moing, V. L., & Reynes, J. (2007). Profound neutropenia resulting from interaction between antiretroviral therapy and vinblastine in a patient with HIV-associated Hodgkin’s disease. European Journal of Haematology, 78(4), 358–360. https://doi.org/10.1111/j.1600-0609.2007.00827.x
Mendeley helps you to discover research relevant for your work.